News Chart NFL Biosciences

Stocks

ALNFL

FR0014003XT0

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-07-31 EDT			5-day change	1st Jan Change
0.8700 ^EUR	+2.72%		+4.82%	-26.15%

07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI
07-07	Nfl Biosciences Presents Three Scientific Communications on Nfl-101 and Nfl-102 At 2026 Srnt-Europe Conference	CI

8f40ce695b0122689.EJIfXAU8ZDjTaWCbhXidZgM7dmvL6icaQw8bkAJArt8.f81SPVEFEluRMDXt0S38UnFeAh-fvGtUCFBeplYu-KV22mg3NEQ-AOVfDw~37763d10726e9fa8b12839ba64f30d4d